Allergan - Pfizer deal in doubt

ReutersNewsPublished: April 5, 20167 views
Published: April 5, 2016

Pfizer is leaning towards abandoning its $160 billion merger deal with Allergan. If the deal collapses, analysts say, both companies could pursue other acquisitions. Fred Katayama reports.

Be the first to suggest a tag

    Comments

    0 comments